[PROLONGED ACTIVATION OF PROTEIN ANABOLISM IN GYNECOLOGICAL ONCOLOGY AND ITS REPERCUSSIONS ON LIVER FUNCTION].
D000230:Adenocarcinoma; D000410:Alanine Transaminase; D045930:Anabolic Agents; D001219:Aspartate Aminotransferases; D001663:Bilirubin; D001798:Blood Proteins; D002294:Carcinoma, Squamous Cell; D056486:Chemical and Drug Induced Liver Injury; D051263:D-Alanine Transaminase; D005260:Female; D005833:Genital Neoplasms, Female; D006505:Hepatitis; D006506:Hepatitis A; D006801:Humans; D008099:Liver / Q000201:enzymology* / Q000502:physiology*; D008111:Liver Function Tests; D010600:Pharmacology; D011506:Proteins / Q000378:metabolism*; D013256:Steroids; D013448:Sulfobromophthalein; D014116:Toxicology; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms
D045930:Anabolic Agents; D001798:Blood Proteins; D011506:Proteins; D013256:Steroids; D013448:Sulfobromophthalein; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D051263:D-Alanine Transaminase; D001663:Bilirubin
ADENOCARCINOMA; ALANINE AMINOTRANSFERASE; ANABOLIC STEROIDS; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD PROTEINS; CARCINOMA, EPIDERMOID; CERVIX NEOPLASMS; GYNECOLOGIC NEOPLASMS; HEPATITIS, TOXIC; LIVER ENZYMOLOGY; LIVER FUNCTION; LIVER FUNCTION TESTS; PHARMACOLOGY; PROTEIN METABOLISM; SULFOBROMOPHTHALEIN; TOXICOLOGIC REPORT; UTERINE NEOPLASMS
L'ATTIVAZIONE PROTRATTA DELL'ANABOLISMO PROTEICO IN ONCOLOGIA GINECOLOGICA NEI SUOI RIFLESSI SULLA FUNZIONALIT'A EPATICA.